Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Are Outcomes After Myeloablative Conditioning Regimen in Double Cord Blood Transplantation (UCBT) Better Than Single UCBT for Adults with Acute Leukemia in Remission?.

Annalisa Ruggeri, MD, Henrique Bittencourt, MD, Guillermo Sanz, Alessandro Rambaldi, MD, Ibrahim Yakoub-Agha, MD, PhD, Josep-Maria Ribera, MD, PhD, William Arcese, MD, Lionel Mannone, MD, J. Sierra, MD, Carlos Solano, MD, Samir Kanaan Nabhan, MD, Luciana Tucunduva, Fernanda Volt, Chantal Kenzey, Eliane Gluckman, MD, PhD, Myriam Labopin, Vanderson Rocha, MD, PhD

Blood (2012) 120 (21): 3083.

https://doi.org/10.1182/blood.V120.21.3083.3083

Published: 2012

Journal Articles

T-Cell Receptor Signaling Proteins, BCL10 and Phosphorylated-P65 NFKB, Are Expressed in Peripheral T-Cell Lymphomas and Associated with Clinical Outcome

Javier Briones, Iñigo Espinosa, Julio Delgado, J. Sierra

Blood (2008) 112 (11): 2820.

https://doi.org/10.1182/blood.V112.11.2820.2820

Published: 2008

Journal Articles

Non-Myeloablative Hematopoietic Stem Cell Transplantation in Older Patients with AML and MDS: Results from the Center for International Blood and Marrow Transplant Research (CIBMTR)

Brian McClune, DO, Daniel J. Weisdorf, MD, John F. DiPersio, MD, PhD, Armand Keating, MD, Tanya L. Pedersen, Gisela Tunes da Silva, PhD., J. Sierra, MD, Martin S. Tallman, MD, Sergio A. Giralt

Blood (2008) 112 (11): 346.

https://doi.org/10.1182/blood.V112.11.346.346

Published: 2008

Journal Articles

Validation of Comorbidity Indexes in Reduced-Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation. the Hematopoietic Cell Transplantation Comorbidity Index Is the Best Predictor of NRM and Survival.

Pere Barba, Jose Luis Piñana, Alex Amoros, David Valcárcel, Rodrigo Martino, Anna Sureda, Javier Briones, Julio Delgado, Miquel Granell, Salut Brunet, Ma. Rosa Suñol, J. Sierra, MD

Blood (2008) 112 (11): 3277.

https://doi.org/10.1182/blood.V112.11.3277.3277

Published: 2008

Journal Articles

Non Myeloablative Allogeneic Related Transplant in Patients with Aggressive B Cell Lymphoma: Results of Two Multicenter Spanish Trials. The GELTAMO Group.

M.D. Caballero, J. Briones, M.V Mateos, J.F. Tomás, R. Martino, J. de la Serna, J.L. Díez, J.A. Pérez-Simón, A. Sureda, J. Sarrá, J. García-Laraña, J.M. Ribera, J. Sierra, J.F. San Miguel

Blood (2007) 110 (11): 5053.

https://doi.org/10.1182/blood.V110.11.5053.5053

Published: 2007

Journal Articles

Reduced Intensity Conditioning Unrelated Transplant Plus Cyclosporine and MMF as GVHD Prophylaxis: Results of a Prospective Study.

J.A. Perez-Simon, MD, PhD, R. Martino, MD, PhD, R. de la Camara, MD, PhD, J. Perez de Oteiza, MD, PhD, J.M. Moraleda, MD, PhD, M. Diez-Campelo, MD, PhD, A. Sureda, MD, PhD, A. Alegre, MD, PhD, J. Sierra, MD, PhD, J.F. San Miguel, MD, PhD

Blood (2005) 106 (11): 5312.

https://doi.org/10.1182/blood.V106.11.5312.5312

Published: 2005

Journal Articles

Impact of In Vivo T-Cell Depletion on Outcome Following Reduced Intensity Transplantation for Hodgkin Lymphoma: Comparison between 2 Prospective Studies.

K. S. Peggs, A. Sureda, A. Hunter, M. D. Caballero, J. Cavet, A. Urbano-Ispizua, A. Parker, J. M. Ribera, P. Mahendra, M. A. Canales, D. Milligan, J. C. Hernandez-Boluda, E. C. Morris, I. Alvarez, A. H. Goldstone, D. C. Linch, J. Sierra, S. Mackinnon

Blood (2004) 104 (11): 807.

https://doi.org/10.1182/blood.V104.11.807.807

Published: 2004

Journal Articles

Non Myeloablative Transplant in Patients with Indolent Non-Hodgkin’s Lymphoma (NHL): Results of Two Prospectives Multicenter Trials.

M.D. Caballero, R. Martino, M.V. Mateos, J. Briones, J. de la Serna, J.F. Tomas, R. Arranz, J.L. Diez, V. Rubio, Josep Maria Ribera, J.M. Moraleda, G. Sanz, A. Urbano, J. Sarrá, A. Sampol, J. Sierra

Blood (2004) 104 (11): 2318.

https://doi.org/10.1182/blood.V104.11.2318.2318

Published: 2004

Journal Articles

Fludarabine and Busulfan-Based Reduced Intensity Conditioning (RIC) Allogeneic HLA-Identical Transplantation (allo-SCT) with or without Anti-Thymocyte Globulin (ATG): Comparison between Two Prospective Studies in Patients with Myeloid Malignancies.

Mohamad Mohty, R. Martino, C. Faucher, J.A. Perez-Simon, N. Vey, M.D. Caballero, J.A. Gastaut, J. San Miguel, D. Blaise, J. Sierra

Blood (2004) 104 (11): 1241.

https://doi.org/10.1182/blood.V104.11.1241.1241

Published: 2004

Journal Articles

Whether methotrexate administration in graft-versus-host disease prophylaxis significantly delays the engraftment in allogeneic peripheral blood progenitor cell transplantation [letter; comment]

A Urbano-Ispizua, E Carreras, J Sierra, M Rovira, C Rozman

Blood (1995) 86 (2): 836–837.

https://doi.org/10.1182/blood.V86.2.836.bloodjournal862836

Published: 1995

Journal Articles

Interleukin-2 after T-cell-depleted allogeneic bone marrow transplantation [letter]

C Salgado, A Urbano-Ispizua, C Rozman, J Sierra, E Carreras, E Montserrat

Blood (1995) 85 (2): 600–601.

https://doi.org/10.1182/blood.V85.2.600.600

Published: 1995

Journal Articles

Autologous bone marrow transplantation for non-Hodgkin's lymphoma in first remission [letter; comment]

J Sierra, E Conde, E Montserrat

Blood (1993) 81 (7): 1968–1969.

https://doi.org/10.1182/blood.V81.7.1968.1968

Published: 1993

NARROW

Are Outcomes After Myeloablative Conditioning Regimen in Double Cord Blood Transplantation (UCBT) Better Than Single UCBT for Adults with Acute Leukemia in Remission?.

T-Cell Receptor Signaling Proteins, BCL10 and Phosphorylated-P65 NFKB, Are Expressed in Peripheral T-Cell Lymphomas and Associated with Clinical Outcome

Non-Myeloablative Hematopoietic Stem Cell Transplantation in Older Patients with AML and MDS: Results from the Center for International Blood and Marrow Transplant Research (CIBMTR)

Validation of Comorbidity Indexes in Reduced-Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation. the Hematopoietic Cell Transplantation Comorbidity Index Is the Best Predictor of NRM and Survival.

Non Myeloablative Allogeneic Related Transplant in Patients with Aggressive B Cell Lymphoma: Results of Two Multicenter Spanish Trials. The GELTAMO Group.

Reduced Intensity Conditioning Unrelated Transplant Plus Cyclosporine and MMF as GVHD Prophylaxis: Results of a Prospective Study.

Impact of In Vivo T-Cell Depletion on Outcome Following Reduced Intensity Transplantation for Hodgkin Lymphoma: Comparison between 2 Prospective Studies.

Non Myeloablative Transplant in Patients with Indolent Non-Hodgkin’s Lymphoma (NHL): Results of Two Prospectives Multicenter Trials.

Fludarabine and Busulfan-Based Reduced Intensity Conditioning (RIC) Allogeneic HLA-Identical Transplantation (allo-SCT) with or without Anti-Thymocyte Globulin (ATG): Comparison between Two Prospective Studies in Patients with Myeloid Malignancies.

Whether methotrexate administration in graft-versus-host disease prophylaxis significantly delays the engraftment in allogeneic peripheral blood progenitor cell transplantation [letter; comment]

Interleukin-2 after T-cell-depleted allogeneic bone marrow transplantation [letter]

Autologous bone marrow transplantation for non-Hodgkin's lymphoma in first remission [letter; comment]

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only